May 20 , 2013 (Orlando) - Digestive Disease Week (DDW)
Guidepoint hosted group meetings at the DDW conference with discussions led by KOLs from leading medical centers across the nation.
May 9, 2013 (Denver) - Heart Rhythm Society (HRS)
Guidepoint hosted group meetings with Guidepoint Global Advisors and Institutional Investors at the 2013 HRS conference
May 7, 2013 (Seattle) - Association of Research in Vision and Opthalmology
Guidepoint hosted group meetings with Guidepoint Global Advisors and Institutional Investors at the 2013 ARVO conference.
May 5, 2013 (San Diego) - American Urological Association (AUA)
Guidepoint hosted group meetings with Guidepoint Global Advisors and Clients at the 2013 AUA conference. Meetings included a Chairman of Tumor Oncology at an internationally reknowned hospital, a Medical Director of a 16-person Urology practice, and an Assistant Professor from the Department of Urology at a major University Medical Center.
April 25 , 2013 (Teleconference) - US Agriculture Trends
Guidepoint hosted a teleconference with the Director of Financial Planning and Analysis at a major U.S. agribusiness company. Topics included the fertilizer retail site explosion in April 2013, the 2012 US drought, the 2013 US supply and demand forecast, 2013 plantings, and a discussion of North American nitrogen companies.
February 15, 2013 (New York) - Guidepoint Launches Major Enhancements to its Client Portal
Guidepoint's Client Portal now includes an Advisor Search Platform and a Quick Poll (Survey) Platform (Follow this link to read full story)
February 15 , 2013 (Orlando) - Lysosomal Disease Network World Symposium (LDN)
Guidepoint hosted Group Meetings with Healthcare Advisors at the LDN World Symposium.
February 14, 2013 (Orlando) - American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium
Guidepoint hosted group meetings with Healthcare Advisors at the 2013 ASCO-GU symposium.
February 14, 2013 (New York) - Orthopedic Surgery: Hip and Knee
Breakfast Meeting with Chief of Orthopedics at a NY Metro Area Medical Center. Potential topics included Stryker GetAroundKnee and OrthoSensor, MAKOplasty hip and knee procedures with RIO®, and a preview of AAOS 2013.
February 6, 2013 (New York) - Nephrology / Iron Replacement / Hyperphosphatemia
Lunch Meeting with VP of Dialysis Services and Director of Clinical Trials at a NY Metro Hospital / Health Network. Planned Nephrology topics included anemia in CKD patients, iron replacement therapies, Hyperphosphatemia, and dialysis services.
February 1, 2013 (New York) - LVADs / Mechanical Circulatory Support
Lunch Meeting with the Medical Director of a Mechanical Circulatory Support and Cardiac Assist Program at a Major NY transplant center. Experienced in implanting LVADs by both Thoratec and HeartWare, planned topics included recent trends and the 2013 outlook for LVAD implantations.
January 31, 2013 (New York) - Healthcare CapEx / Purchasing Trends
Breakfast Meeting with a purchasing and supply chain executive of a six hospital, 1700 bed IDN. Planned topics included purchasing trends and volumes within radiology and imaging equipment, radiation oncology, orthopedic implants, ventilators, infusion pumps, patient monitoring systems, and outsourced surgery services. Responsible for GPO evaluation and selection, the Advisor was also available to discuss the decision process as well as pricing and reimbursement trends.
January 25 , 2013 (San Francisco) - American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium
Guidepoint hosted group meetings with Healthcare Advisors at the 2013 ASCO-GI symposium.
January 23, 2013 (New York) - Parkinson's Disease
Lunch meeting with a Professor of Neurology at a NY Metro area Medical School. Planned topics included movement disorders, including Parkinson’s and Huntington’s, as well as thoughts and comments on the recent data presented for Pimavanserin.
January 18, 2013 (New York) - Lipids and Hypercholesterolemia
Breakfast Meeting with the Director, Lipoprotein and Metabolic Disorders Research and Professor of Medicine at a prominent NYC Medical School. Planned topics included current trends in treating dyslipidemia, hypercholesterolemia, and other lipoprotein and metabolic disorders. He was also able to comment on the recent approval of Juxtapid (lomitapide) for HoFH and pending approval of Kynamro (mipomersen).
January 8 - 11, 2013 (Las Vegas) - International Consumer Electronics Show
At the 2013 CES, Guidepoint TMT Advisors were available for customized, private meetings with Clients.
January 3, 2013 (New York) - Next Generation Sequencing
Guidepoint hosted a Breakfast Meeting on topics surrounding Next Generation Sequencing with an Advisor who is a Director at the Institution for Personalized Medicine.